Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF16
|
ENSG00000129911.4 | Kruppel like factor 16 |
SP2
|
ENSG00000167182.11 | Sp2 transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr19_1864266_1864809 | KLF16 | 970 | 0.326139 | 0.82 | 6.6e-03 | Click! |
chr19_1863868_1864020 | KLF16 | 377 | 0.705577 | 0.72 | 2.7e-02 | Click! |
chr19_1861832_1862770 | KLF16 | 1266 | 0.230425 | 0.56 | 1.2e-01 | Click! |
chr19_1862984_1863162 | KLF16 | 494 | 0.596893 | 0.31 | 4.2e-01 | Click! |
chr19_1864980_1865206 | KLF16 | 1526 | 0.200148 | 0.08 | 8.4e-01 | Click! |
chr17_45982661_45983102 | SP2 | 9365 | 0.101358 | -0.80 | 9.2e-03 | Click! |
chr17_45973604_45973975 | SP2 | 273 | 0.844355 | 0.71 | 3.3e-02 | Click! |
chr17_45959589_45959832 | SP2 | 13806 | 0.100431 | -0.70 | 3.7e-02 | Click! |
chr17_45972820_45973188 | SP2 | 512 | 0.658643 | 0.66 | 5.5e-02 | Click! |
chr17_45973983_45974807 | SP2 | 879 | 0.432315 | 0.64 | 6.4e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr10_22609853_22610108 | 2.59 |
BMI1 |
BMI1 polycomb ring finger oncogene |
160 |
0.94 |
chr1_161038546_161039545 | 2.21 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr19_47760300_47760580 | 2.19 |
CCDC9 |
coiled-coil domain containing 9 |
349 |
0.83 |
chr8_145027093_145027557 | 2.18 |
PLEC |
plectin |
763 |
0.48 |
chr19_42758223_42758597 | 2.11 |
ERF |
Ets2 repressor factor |
359 |
0.64 |
chr14_93118654_93119048 | 2.03 |
RIN3 |
Ras and Rab interactor 3 |
5 |
0.99 |
chr14_105218972_105219273 | 1.98 |
SIVA1 |
SIVA1, apoptosis-inducing factor |
315 |
0.83 |
chr4_6201674_6201940 | 1.91 |
JAKMIP1 |
janus kinase and microtubule interacting protein 1 |
475 |
0.88 |
chr20_48806660_48807137 | 1.86 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
478 |
0.82 |
chr11_2292275_2292426 | 1.84 |
ASCL2 |
achaete-scute family bHLH transcription factor 2 |
168 |
0.93 |
chr19_17008131_17008363 | 1.82 |
CPAMD8 |
C3 and PZP-like, alpha-2-macroglobulin domain containing 8 |
1221 |
0.33 |
chr19_1077655_1078093 | 1.81 |
HMHA1 |
histocompatibility (minor) HA-1 |
432 |
0.68 |
chr4_56719650_56719801 | 1.79 |
EXOC1 |
exocyst complex component 1 |
57 |
0.98 |
chr20_62708665_62709256 | 1.77 |
RGS19 |
regulator of G-protein signaling 19 |
1885 |
0.17 |
chr20_62272433_62273064 | 1.77 |
STMN3 |
stathmin-like 3 |
11371 |
0.09 |
chr15_69110570_69110988 | 1.75 |
ANP32A |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
2446 |
0.33 |
chr11_64510621_64511071 | 1.72 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
415 |
0.76 |
chr17_38478045_38478318 | 1.68 |
RARA |
retinoic acid receptor, alpha |
3644 |
0.15 |
chr4_2538188_2538339 | 1.67 |
RNF4 |
ring finger protein 4 |
46725 |
0.12 |
chr14_105767785_105767936 | 1.65 |
BRF1 |
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
245 |
0.85 |
chr11_725898_726201 | 1.65 |
AP006621.9 |
|
998 |
0.31 |
chr11_59436048_59436268 | 1.64 |
PATL1 |
protein associated with topoisomerase II homolog 1 (yeast) |
295 |
0.7 |
chr12_50221981_50222334 | 1.64 |
NCKAP5L |
NCK-associated protein 5-like |
51 |
0.65 |
chr5_154062019_154062378 | 1.63 |
ENSG00000221552 |
. |
3138 |
0.22 |
chr22_44577166_44577317 | 1.61 |
PARVG |
parvin, gamma |
16 |
0.99 |
chr9_134152676_134153362 | 1.60 |
FAM78A |
family with sequence similarity 78, member A |
1085 |
0.5 |
chr9_139001578_139001729 | 1.59 |
C9orf69 |
chromosome 9 open reading frame 69 |
8467 |
0.19 |
chr12_133046242_133046397 | 1.59 |
MUC8 |
mucin 8 |
4407 |
0.24 |
chr17_3598807_3599359 | 1.59 |
P2RX5 |
purinergic receptor P2X, ligand-gated ion channel, 5 |
244 |
0.86 |
chr11_62380318_62380537 | 1.58 |
EML3 |
echinoderm microtubule associated protein like 3 |
190 |
0.49 |
chr19_50002920_50003191 | 1.57 |
hsa-mir-150 |
hsa-mir-150 |
726 |
0.27 |
chr22_26823969_26824219 | 1.57 |
ASPHD2 |
aspartate beta-hydroxylase domain containing 2 |
1145 |
0.46 |
chr7_63360438_63360674 | 1.56 |
ENSG00000263891 |
. |
890 |
0.66 |
chr9_139685367_139685521 | 1.54 |
TMEM141 |
transmembrane protein 141 |
363 |
0.42 |
chr19_39616447_39616996 | 1.54 |
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4 |
247 |
0.88 |
chr11_20178120_20178396 | 1.54 |
DBX1 |
developing brain homeobox 1 |
3612 |
0.29 |
chr6_130341357_130341579 | 1.52 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
168 |
0.97 |
chr12_1100531_1100778 | 1.52 |
ERC1 |
ELKS/RAB6-interacting/CAST family member 1 |
134 |
0.7 |
chr15_81589438_81589936 | 1.50 |
IL16 |
interleukin 16 |
433 |
0.84 |
chr22_42322815_42322966 | 1.49 |
TNFRSF13C |
tumor necrosis factor receptor superfamily, member 13C |
68 |
0.94 |
chr21_45660934_45661560 | 1.49 |
ICOSLG |
inducible T-cell co-stimulator ligand |
398 |
0.76 |
chr19_14474047_14474891 | 1.49 |
CD97 |
CD97 molecule |
17499 |
0.14 |
chr15_68176890_68177288 | 1.49 |
ENSG00000206625 |
. |
44706 |
0.17 |
chr19_18209757_18210181 | 1.48 |
IL12RB1 |
interleukin 12 receptor, beta 1 |
215 |
0.88 |
chr19_13206703_13207270 | 1.47 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
6695 |
0.11 |
chr16_50714281_50714981 | 1.46 |
SNX20 |
sorting nexin 20 |
592 |
0.64 |
chr1_9712713_9712881 | 1.45 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
994 |
0.46 |
chr7_6543400_6543638 | 1.45 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
19646 |
0.12 |
chr17_43299403_43299689 | 1.44 |
CTD-2020K17.1 |
|
43 |
0.75 |
chr1_154981282_154981433 | 1.44 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5567 |
0.08 |
chrX_118827157_118827473 | 1.42 |
SEPT6 |
septin 6 |
18 |
0.98 |
chr17_26698322_26698638 | 1.42 |
SARM1 |
sterile alpha and TIR motif containing 1 |
203 |
0.74 |
chr19_39903070_39903221 | 1.42 |
PLEKHG2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
80 |
0.92 |
chr17_76255043_76255413 | 1.42 |
TMEM235 |
transmembrane protein 235 |
27106 |
0.12 |
chr19_39894109_39894559 | 1.42 |
ZFP36 |
ZFP36 ring finger protein |
3119 |
0.1 |
chr1_26606672_26606961 | 1.42 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
203 |
0.9 |
chr17_26367818_26368453 | 1.40 |
NLK |
nemo-like kinase |
1047 |
0.46 |
chr11_64511299_64511931 | 1.39 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
2 |
0.96 |
chr14_105527834_105528220 | 1.38 |
GPR132 |
G protein-coupled receptor 132 |
3740 |
0.23 |
chr3_129830565_129830801 | 1.38 |
FAM86HP |
family with sequence similarity 86, member H, pseudogene |
368 |
0.85 |
chr17_73840046_73840332 | 1.38 |
UNC13D |
unc-13 homolog D (C. elegans) |
226 |
0.84 |
chr16_21513626_21513801 | 1.38 |
CTD-2547E10.2 |
|
506 |
0.75 |
chr13_52158020_52158278 | 1.37 |
WDFY2 |
WD repeat and FYVE domain containing 2 |
495 |
0.7 |
chr3_193973103_193973434 | 1.36 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
98779 |
0.06 |
chr16_69600288_69600492 | 1.35 |
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
136 |
0.88 |
chr6_143266416_143266570 | 1.35 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
155 |
0.97 |
chr19_8641850_8642121 | 1.35 |
MYO1F |
myosin IF |
337 |
0.81 |
chr19_3359638_3360022 | 1.35 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
149 |
0.96 |
chr2_10184175_10184326 | 1.34 |
KLF11 |
Kruppel-like factor 11 |
52 |
0.96 |
chr8_144108277_144108585 | 1.34 |
LY6E |
lymphocyte antigen 6 complex, locus E |
8457 |
0.17 |
chr12_122231286_122231671 | 1.34 |
RHOF |
ras homolog family member F (in filopodia) |
212 |
0.92 |
chr1_6525804_6526081 | 1.34 |
TNFRSF25 |
tumor necrosis factor receptor superfamily, member 25 |
225 |
0.88 |
chr19_1257963_1258114 | 1.34 |
CIRBP |
cold inducible RNA binding protein |
1346 |
0.23 |
chrX_15756367_15757484 | 1.33 |
CA5B |
carbonic anhydrase VB, mitochondrial |
532 |
0.77 |
chr19_51228076_51228227 | 1.33 |
CLEC11A |
C-type lectin domain family 11, member A |
1371 |
0.27 |
chr2_136873940_136874440 | 1.33 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
377 |
0.92 |
chr17_27039009_27039183 | 1.32 |
PROCA1 |
protein interacting with cyclin A1 |
224 |
0.75 |
chr12_133021289_133021651 | 1.31 |
MUC8 |
mucin 8 |
29256 |
0.17 |
chr17_73851056_73851207 | 1.31 |
WBP2 |
WW domain binding protein 2 |
154 |
0.9 |
chr19_39825870_39826313 | 1.30 |
GMFG |
glia maturation factor, gamma |
554 |
0.58 |
chr12_4380314_4380587 | 1.30 |
CCND2 |
cyclin D2 |
2488 |
0.24 |
chr6_44238340_44238491 | 1.29 |
TMEM151B |
transmembrane protein 151B |
65 |
0.95 |
chr19_872645_872938 | 1.29 |
CFD |
complement factor D (adipsin) |
13101 |
0.07 |
chr8_21769341_21769492 | 1.29 |
DOK2 |
docking protein 2, 56kDa |
1758 |
0.36 |
chr19_17958305_17958511 | 1.29 |
JAK3 |
Janus kinase 3 |
418 |
0.74 |
chr14_90863868_90864201 | 1.27 |
CALM1 |
calmodulin 1 (phosphorylase kinase, delta) |
572 |
0.74 |
chr19_13906051_13906257 | 1.27 |
ZSWIM4 |
zinc finger, SWIM-type containing 4 |
120 |
0.9 |
chr1_228247282_228247590 | 1.27 |
ARF1 |
ADP-ribosylation factor 1 |
22925 |
0.12 |
chr15_77287809_77288285 | 1.26 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
132 |
0.96 |
chr22_40058332_40058676 | 1.26 |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
91746 |
0.07 |
chr17_43487096_43487739 | 1.26 |
ARHGAP27 |
Rho GTPase activating protein 27 |
335 |
0.82 |
chr22_41841745_41842536 | 1.26 |
TOB2 |
transducer of ERBB2, 2 |
649 |
0.64 |
chr19_4064959_4065214 | 1.26 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
644 |
0.56 |
chr19_49838375_49839003 | 1.25 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr17_81060660_81060811 | 1.24 |
METRNL |
meteorin, glial cell differentiation regulator-like |
8741 |
0.25 |
chr12_57870819_57871184 | 1.24 |
ARHGAP9 |
Rho GTPase activating protein 9 |
566 |
0.53 |
chr12_122241648_122241827 | 1.24 |
SETD1B |
SET domain containing 1B |
349 |
0.75 |
chr9_131012810_131012961 | 1.23 |
ENSG00000264823 |
. |
5576 |
0.09 |
chr9_33446798_33447442 | 1.23 |
AQP3 |
aquaporin 3 (Gill blood group) |
489 |
0.76 |
chr12_54813071_54813467 | 1.23 |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
25 |
0.8 |
chr2_242823909_242824060 | 1.23 |
AC131097.3 |
|
115 |
0.94 |
chr21_40685017_40685283 | 1.23 |
BRWD1 |
bromodomain and WD repeat domain containing 1 |
346 |
0.75 |
chr20_32581185_32581435 | 1.22 |
RALY |
RALY heterogeneous nuclear ribonucleoprotein |
142 |
0.97 |
chr17_76128459_76128696 | 1.22 |
TMC6 |
transmembrane channel-like 6 |
89 |
0.94 |
chr5_133801504_133801725 | 1.21 |
ENSG00000207222 |
. |
34361 |
0.12 |
chr5_34929563_34929714 | 1.21 |
DNAJC21 |
DnaJ (Hsp40) homolog, subfamily C, member 21 |
60 |
0.97 |
chr12_2903621_2904135 | 1.21 |
FKBP4 |
FK506 binding protein 4, 59kDa |
241 |
0.88 |
chr13_114428270_114428568 | 1.21 |
TMEM255B |
transmembrane protein 255B |
33797 |
0.18 |
chr17_7788638_7788948 | 1.21 |
LSMD1 |
LSM domain containing 1 |
266 |
0.71 |
chr20_54933667_54933884 | 1.21 |
FAM210B |
family with sequence similarity 210, member B |
196 |
0.94 |
chr17_72733506_72734386 | 1.21 |
RAB37 |
RAB37, member RAS oncogene family |
575 |
0.59 |
chr1_21620200_21620457 | 1.20 |
RP5-1071N3.1 |
|
545 |
0.47 |
chr10_76585278_76585925 | 1.20 |
KAT6B |
K(lysine) acetyltransferase 6B |
261 |
0.95 |
chr15_45315162_45315313 | 1.20 |
SORD |
sorbitol dehydrogenase |
65 |
0.95 |
chrX_134555719_134555870 | 1.20 |
ENSG00000201440 |
. |
6416 |
0.24 |
chr9_134147000_134147362 | 1.20 |
FAM78A |
family with sequence similarity 78, member A |
1271 |
0.44 |
chr1_21978657_21978808 | 1.20 |
RAP1GAP |
RAP1 GTPase activating protein |
384 |
0.87 |
chr19_49217598_49217896 | 1.19 |
MAMSTR |
MEF2 activating motif and SAP domain containing transcriptional regulator |
2353 |
0.14 |
chr19_11449786_11450552 | 1.19 |
RAB3D |
RAB3D, member RAS oncogene family |
175 |
0.88 |
chr1_28199069_28199319 | 1.19 |
THEMIS2 |
thymocyte selection associated family member 2 |
115 |
0.94 |
chr11_64107746_64107914 | 1.19 |
CCDC88B |
coiled-coil domain containing 88B |
135 |
0.9 |
chr8_144328822_144328973 | 1.18 |
ZFP41 |
ZFP41 zinc finger protein |
94 |
0.95 |
chrX_1573017_1573223 | 1.18 |
ASMTL |
acetylserotonin O-methyltransferase-like |
465 |
0.82 |
chr7_50345445_50345596 | 1.18 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
1142 |
0.64 |
chr2_69002223_69002932 | 1.18 |
ARHGAP25 |
Rho GTPase activating protein 25 |
505 |
0.84 |
chr12_70759576_70760191 | 1.18 |
KCNMB4 |
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
173 |
0.96 |
chr7_6543759_6544005 | 1.18 |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
20009 |
0.12 |
chr8_103251470_103251823 | 1.17 |
KB-431C1.4 |
|
24 |
0.81 |
chr21_44073846_44074183 | 1.17 |
PDE9A |
phosphodiesterase 9A |
91 |
0.97 |
chr19_10405987_10406645 | 1.17 |
ICAM5 |
intercellular adhesion molecule 5, telencephalin |
4663 |
0.08 |
chr19_41109976_41110366 | 1.17 |
ENSG00000266164 |
. |
2784 |
0.18 |
chr1_9189517_9189890 | 1.17 |
GPR157 |
G protein-coupled receptor 157 |
474 |
0.79 |
chr3_129036411_129036562 | 1.17 |
H1FX-AS1 |
H1FX antisense RNA 1 |
463 |
0.7 |
chr20_50158140_50158637 | 1.17 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
870 |
0.72 |
chr12_8395790_8395992 | 1.16 |
FAM86FP |
family with sequence similarity 86, member F, pseudogene |
347 |
0.83 |
chr1_154297288_154297551 | 1.16 |
ATP8B2 |
ATPase, aminophospholipid transporter, class I, type 8B, member 2 |
610 |
0.54 |
chr11_441689_441900 | 1.16 |
ANO9 |
anoctamin 9 |
217 |
0.82 |
chr1_209943004_209943387 | 1.16 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1235 |
0.37 |
chr19_14277944_14278210 | 1.15 |
LPHN1 |
latrophilin 1 |
5729 |
0.13 |
chr2_24299498_24299649 | 1.15 |
SF3B14 |
Pre-mRNA branch site protein p14 |
260 |
0.86 |
chr10_75757286_75757724 | 1.15 |
VCL |
vinculin |
367 |
0.86 |
chr19_1104440_1104738 | 1.15 |
GPX4 |
glutathione peroxidase 4 |
174 |
0.9 |
chr11_71934379_71934736 | 1.14 |
INPPL1 |
inositol polyphosphate phosphatase-like 1 |
188 |
0.89 |
chr19_49521048_49521234 | 1.14 |
LHB |
luteinizing hormone beta polypeptide |
803 |
0.32 |
chr3_125634965_125635218 | 1.14 |
FAM86JP |
family with sequence similarity 86, member J, pseudogene |
376 |
0.86 |
chr9_100745668_100746275 | 1.14 |
ANP32B |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
328 |
0.85 |
chr16_31488931_31489094 | 1.14 |
TGFB1I1 |
transforming growth factor beta 1 induced transcript 1 |
4265 |
0.1 |
chr1_26644827_26645344 | 1.13 |
UBXN11 |
UBX domain protein 11 |
231 |
0.76 |
chr6_32159695_32160229 | 1.13 |
GPSM3 |
G-protein signaling modulator 3 |
683 |
0.42 |
chr13_30510013_30510639 | 1.13 |
LINC00572 |
long intergenic non-protein coding RNA 572 |
9538 |
0.3 |
chr12_27090977_27091227 | 1.13 |
ASUN |
asunder spermatogenesis regulator |
135 |
0.61 |
chr11_19262741_19262892 | 1.13 |
E2F8 |
E2F transcription factor 8 |
318 |
0.9 |
chr17_21187518_21187824 | 1.13 |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
313 |
0.89 |
chr19_1863868_1864020 | 1.13 |
KLF16 |
Kruppel-like factor 16 |
377 |
0.71 |
chr19_48112390_48112826 | 1.12 |
GLTSCR1 |
glioma tumor suppressor candidate region gene 1 |
228 |
0.91 |
chrX_70837784_70838022 | 1.12 |
CXCR3 |
chemokine (C-X-C motif) receptor 3 |
457 |
0.81 |
chr19_12903915_12904171 | 1.12 |
JUNB |
jun B proto-oncogene |
1733 |
0.14 |
chr20_37434091_37434759 | 1.12 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
58 |
0.98 |
chr16_75590196_75590347 | 1.12 |
TMEM231 |
transmembrane protein 231 |
87 |
0.95 |
chr9_139439215_139440028 | 1.12 |
NOTCH1 |
notch 1 |
693 |
0.35 |
chr1_40157482_40157633 | 1.11 |
HPCAL4 |
hippocalcin like 4 |
196 |
0.61 |
chr20_62272194_62272345 | 1.11 |
STMN3 |
stathmin-like 3 |
11850 |
0.09 |
chr6_130341588_130342312 | 1.11 |
L3MBTL3 |
l(3)mbt-like 3 (Drosophila) |
248 |
0.96 |
chrX_70330517_70330974 | 1.11 |
IL2RG |
interleukin 2 receptor, gamma |
553 |
0.61 |
chr20_44633478_44633997 | 1.11 |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
3810 |
0.15 |
chr9_139438785_139439162 | 1.11 |
NOTCH1 |
notch 1 |
1341 |
0.19 |
chr10_135089818_135090113 | 1.11 |
ADAM8 |
ADAM metallopeptidase domain 8 |
389 |
0.74 |
chr1_154980554_154980872 | 1.11 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5418 |
0.08 |
chr10_111986414_111986565 | 1.11 |
MXI1 |
MAX interactor 1, dimerization protein |
647 |
0.75 |
chrX_129305420_129305680 | 1.11 |
RAB33A |
RAB33A, member RAS oncogene family |
73 |
0.97 |
chr2_233925739_233925978 | 1.11 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
669 |
0.7 |
chr19_16436739_16437476 | 1.10 |
KLF2 |
Kruppel-like factor 2 |
1456 |
0.3 |
chr17_48046517_48046834 | 1.10 |
DLX4 |
distal-less homeobox 4 |
19 |
0.97 |
chr17_1928692_1929031 | 1.10 |
RTN4RL1 |
reticulon 4 receptor-like 1 |
222 |
0.83 |
chr11_46142055_46142270 | 1.10 |
PHF21A |
PHD finger protein 21A |
352 |
0.89 |
chr16_56691251_56692352 | 1.10 |
MT1F |
metallothionein 1F |
54 |
0.92 |
chr20_4804308_4804651 | 1.10 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
188 |
0.95 |
chr1_32665798_32666702 | 1.10 |
CCDC28B |
coiled-coil domain containing 28B |
16 |
0.94 |
chr17_70715796_70716056 | 1.09 |
ENSG00000222545 |
. |
5316 |
0.27 |
chr6_36164778_36164969 | 1.09 |
RP1-179N16.6 |
|
107 |
0.53 |
chr1_9688741_9688898 | 1.09 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
22971 |
0.15 |
chr19_10341979_10342223 | 1.09 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
139 |
0.49 |
chr11_68610311_68610775 | 1.09 |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
1144 |
0.51 |
chr11_64612184_64612335 | 1.08 |
CDC42BPG |
CDC42 binding protein kinase gamma (DMPK-like) |
218 |
0.88 |
chr2_214014184_214015200 | 1.08 |
IKZF2 |
IKAROS family zinc finger 2 (Helios) |
273 |
0.95 |
chrX_19817156_19817441 | 1.08 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
571 |
0.85 |
chr19_12832816_12833175 | 1.08 |
TNPO2 |
transportin 2 |
174 |
0.86 |
chr19_1260409_1260809 | 1.08 |
CIRBP |
cold inducible RNA binding protein |
546 |
0.56 |
chr1_226250003_226250154 | 1.08 |
H3F3A |
H3 histone, family 3A |
301 |
0.66 |
chr19_44008424_44008786 | 1.07 |
PHLDB3 |
pleckstrin homology-like domain, family B, member 3 |
39 |
0.96 |
chr2_65659623_65660251 | 1.07 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
166 |
0.97 |
chr14_24616040_24616456 | 1.07 |
RNF31 |
ring finger protein 31 |
152 |
0.5 |
chr2_220143754_220143905 | 1.07 |
DNAJB2 |
DnaJ (Hsp40) homolog, subfamily B, member 2 |
160 |
0.84 |
chr11_129765183_129765434 | 1.07 |
NFRKB |
nuclear factor related to kappaB binding protein |
144 |
0.97 |
chr12_118499283_118499905 | 1.07 |
WSB2 |
WD repeat and SOCS box containing 2 |
385 |
0.87 |
chrX_9432622_9433173 | 1.06 |
TBL1X |
transducin (beta)-like 1X-linked |
151 |
0.98 |
chr11_67250873_67251362 | 1.06 |
AIP |
aryl hydrocarbon receptor interacting protein |
605 |
0.49 |
chr17_37558539_37558828 | 1.06 |
FBXL20 |
F-box and leucine-rich repeat protein 20 |
93 |
0.9 |
chr22_24105585_24106072 | 1.06 |
C22orf15 |
chromosome 22 open reading frame 15 |
418 |
0.68 |
chr11_77705711_77705938 | 1.05 |
INTS4 |
integrator complex subunit 4 |
100 |
0.95 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.2 | 3.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 2.1 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
1.0 | 1.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
1.0 | 3.0 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
1.0 | 5.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.0 | 3.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.0 | 2.9 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
1.0 | 3.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.9 | 2.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 0.9 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.9 | 3.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 9.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.9 | 2.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.9 | 2.6 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.8 | 0.8 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.8 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.8 | 3.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.8 | 2.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.8 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.8 | 3.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.8 | 3.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.7 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 1.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.7 | 2.2 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.7 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.7 | 2.0 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.7 | 3.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 0.7 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.7 | 2.0 | GO:0097205 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.7 | 3.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.6 | 5.7 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.6 | 1.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 1.9 | GO:0001711 | endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
0.6 | 0.6 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.6 | 1.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.6 | 6.2 | GO:0051322 | anaphase(GO:0051322) |
0.6 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.6 | 1.8 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.6 | 1.8 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.6 | 2.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.6 | 2.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.6 | 2.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.6 | 2.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 1.7 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.6 | 2.2 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.6 | 1.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 2.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 1.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 1.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 1.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.6 | 1.1 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.5 | 1.6 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.5 | 7.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 1.6 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.5 | 0.5 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 3.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.5 | 1.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 1.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 1.6 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.5 | 1.6 | GO:0001821 | histamine secretion(GO:0001821) |
0.5 | 1.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 2.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.5 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 0.5 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.5 | 2.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.5 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.5 | 2.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.5 | 2.5 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.5 | 1.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 1.0 | GO:1903959 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) regulation of anion transmembrane transport(GO:1903959) |
0.5 | 2.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 3.9 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.5 | 1.5 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.5 | 3.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.5 | 1.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 0.5 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.5 | 1.4 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.5 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.5 | 2.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.5 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 0.9 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.5 | 1.4 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.5 | 1.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 3.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.5 | 3.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 1.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 0.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.5 | 5.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.5 | 0.9 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 2.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 1.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 0.4 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.4 | 2.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.4 | 2.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 1.3 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.4 | 2.2 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.4 | 0.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.4 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 0.4 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.4 | 1.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 7.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.4 | 3.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.4 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.4 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 2.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 0.9 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.4 | 1.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.4 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.7 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.4 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.4 | 3.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 0.4 | GO:0043368 | positive T cell selection(GO:0043368) |
0.4 | 0.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.4 | 2.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.4 | 1.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 0.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.4 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 0.8 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.2 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 2.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.4 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.4 | 2.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 3.1 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.4 | 2.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 0.8 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.4 | 1.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.4 | 0.8 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 1.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.4 | 1.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.4 | 1.2 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 1.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.4 | 1.9 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.4 | 5.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.4 | 0.7 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.4 | 0.4 | GO:2000380 | regulation of mesodermal cell fate specification(GO:0042661) regulation of mesoderm development(GO:2000380) |
0.4 | 1.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.4 | 3.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.4 | 0.7 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.4 | 8.2 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.4 | 9.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.4 | 1.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.4 | 1.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.4 | 5.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.4 | 1.5 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.4 | 1.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.4 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.8 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.4 | 1.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 0.4 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.4 | 2.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 5.1 | GO:0075733 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.4 | 1.1 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 0.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.4 | 1.4 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.4 | 7.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.4 | 1.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 0.4 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
0.4 | 1.8 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.4 | 1.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.4 | 1.8 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 1.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 0.7 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 1.0 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.3 | 0.3 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 1.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.3 | 4.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.7 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.3 | 6.1 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.0 | GO:0033622 | integrin activation(GO:0033622) |
0.3 | 1.3 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.3 | 3.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 3.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.3 | 0.3 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.3 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.3 | 1.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.3 | 1.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.3 | 0.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 3.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.7 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 3.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 0.6 | GO:0051458 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.3 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 1.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 1.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 | 2.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.3 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.9 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 0.3 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.3 | 2.5 | GO:0034311 | diol metabolic process(GO:0034311) |
0.3 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.9 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.3 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.9 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.3 | 0.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 0.9 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 0.9 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.3 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 0.6 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.3 | GO:0002666 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 14.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 1.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 1.2 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.3 | 0.9 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 0.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.3 | 3.9 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.3 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 3.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.3 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.3 | 1.5 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.3 | 0.9 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 3.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 0.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.3 | 2.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.3 | 0.9 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.3 | 0.9 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.3 | 0.6 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 0.9 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.3 | 2.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.6 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 2.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 3.4 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.3 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.8 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 2.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 0.6 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.3 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.3 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.3 | 1.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 2.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 0.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.5 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.3 | 0.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 1.4 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.3 | 0.5 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.3 | 1.3 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.3 | 6.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 7.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 1.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 0.8 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 0.3 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.8 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 5.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.5 | GO:0051136 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 2.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.8 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 5.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 3.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 2.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 1.0 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.3 | 1.3 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.3 | 1.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 1.3 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.3 | 3.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 1.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.3 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 1.5 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 0.5 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 2.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 1.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.3 | 1.0 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.3 | 2.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 56.3 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 4.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 0.3 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.3 | 0.3 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.3 | 0.5 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.3 | 0.8 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 0.3 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.3 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 3.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.3 | 0.3 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.3 | 0.8 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.5 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.2 | 2.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.2 | 0.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.2 | GO:0072577 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.2 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 1.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) regulation of translational initiation in response to stress(GO:0043558) |
0.2 | 1.9 | GO:1902001 | fatty acid transmembrane transport(GO:1902001) |
0.2 | 1.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.2 | 0.2 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.2 | 0.5 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.2 | 3.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.2 | 0.2 | GO:0002925 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 1.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 1.0 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.5 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.9 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 1.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 5.4 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 8.1 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 1.9 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.2 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 1.2 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine production(GO:0032682) negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.7 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.2 | 0.7 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 0.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.2 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.2 | 1.4 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 7.6 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.2 | GO:0002524 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.2 | 4.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 1.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.4 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.2 | 1.1 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 2.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.2 | 0.7 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 2.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 1.1 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.9 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 1.1 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.2 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.2 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 1.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.9 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.2 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.2 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.6 | GO:0070293 | renal absorption(GO:0070293) renal water absorption(GO:0070295) |
0.2 | 3.4 | GO:0051607 | defense response to virus(GO:0051607) |
0.2 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 3.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.4 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.2 | 0.6 | GO:0000239 | pachytene(GO:0000239) |
0.2 | 5.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.6 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.2 | 3.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.2 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 6.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.2 | 0.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 10.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.2 | 0.2 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.2 | 0.6 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.2 | 0.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.2 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 3.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.2 | 0.2 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.2 | 1.6 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.2 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.6 | GO:0015851 | nucleobase transport(GO:0015851) |
0.2 | 0.6 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.2 | 0.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.6 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.6 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.6 | GO:0045010 | actin nucleation(GO:0045010) |
0.2 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.2 | 1.4 | GO:0009209 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.2 | 0.6 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 0.6 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.2 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.2 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 15.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.2 | 0.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.2 | 0.6 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 24.5 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.2 | 1.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 1.3 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.2 | 2.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.2 | 0.8 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.2 | 4.5 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 1.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.6 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 1.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 3.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.2 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.2 | 0.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.2 | 6.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 1.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.2 | 3.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 1.3 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.2 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.2 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.2 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 1.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.2 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.2 | 0.4 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.2 | 1.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.2 | 0.9 | GO:0036230 | granulocyte activation(GO:0036230) |
0.2 | 0.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 0.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.2 | 1.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 1.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.2 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.2 | 0.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.4 | GO:0051168 | nuclear export(GO:0051168) |
0.2 | 0.2 | GO:0060556 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.2 | 0.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.5 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.2 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.3 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.2 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.2 | 0.2 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.2 | 1.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.2 | 3.0 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 1.1 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.5 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.8 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.2 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.5 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.8 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.2 | 2.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 6.1 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 0.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 2.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.6 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.2 | 12.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.2 | 0.2 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.2 | 0.5 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.2 | 1.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 2.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.3 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.5 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.9 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
0.2 | 1.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.2 | 2.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.2 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 0.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.2 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.2 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 1.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 2.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 0.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 0.2 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.3 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.2 | 0.3 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 4.6 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.1 | 0.7 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.2 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 1.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 1.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 1.9 | GO:0031023 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
0.1 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.3 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 0.3 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.1 | 2.0 | GO:0016236 | macroautophagy(GO:0016236) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.6 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.1 | 1.7 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.1 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.1 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.6 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.6 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 1.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.1 | 0.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 4.5 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.1 | 0.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 1.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.3 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 12.8 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.1 | 7.6 | GO:0031497 | chromatin assembly(GO:0031497) |
0.1 | 0.1 | GO:2000095 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.8 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0016458 | gene silencing(GO:0016458) |
0.1 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.6 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 1.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 3.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 1.2 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.1 | 0.1 | GO:0032508 | DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 1.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.2 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 0.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 14.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.1 | 1.1 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.5 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.9 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0075136 | modulation by symbiont of host defense response(GO:0052031) response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
0.1 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 1.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.6 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 1.2 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 1.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 0.8 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.1 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.5 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.2 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.1 | 1.7 | GO:0000084 | mitotic S phase(GO:0000084) |
0.1 | 0.3 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 1.4 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 2.8 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.2 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 3.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.7 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.8 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.1 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.4 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.1 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 2.4 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.1 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.1 | 0.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.1 | 1.0 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 0.1 | GO:0002714 | positive regulation of B cell mediated immunity(GO:0002714) positive regulation of immunoglobulin mediated immune response(GO:0002891) |
0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.3 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 0.8 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.9 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.4 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.2 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.1 | 0.1 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
0.1 | 0.2 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.6 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.1 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 1.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.3 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.1 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.1 | 0.2 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 1.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 3.2 | GO:0043038 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.4 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 0.2 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 6.9 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 0.3 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.2 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.1 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 1.9 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.7 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 0.1 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.2 | GO:0009750 | response to fructose(GO:0009750) |
0.1 | 5.0 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.5 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 2.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.4 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 6.8 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 1.0 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.3 | GO:0016447 | somatic recombination of immunoglobulin gene segments(GO:0016447) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.6 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 3.8 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 0.5 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0009144 | purine nucleoside triphosphate metabolic process(GO:0009144) |
0.1 | 0.6 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.1 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 3.5 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.4 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.1 | 0.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.5 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.1 | 0.2 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 1.9 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
0.1 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) regulation of sodium ion transmembrane transport(GO:1902305) regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 3.7 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.2 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.2 | GO:0010898 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 1.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 6.6 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 1.0 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.1 | 0.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.3 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.1 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 1.5 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 5.1 | GO:0016032 | viral process(GO:0016032) |
0.1 | 0.2 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0042424 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.1 | 7.9 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.8 | GO:0000279 | M phase(GO:0000279) |
0.1 | 1.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 1.9 | GO:0006757 | glycolytic process(GO:0006096) nucleoside diphosphate phosphorylation(GO:0006165) ATP generation from ADP(GO:0006757) |
0.1 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 0.1 | GO:0060158 | nonassociative learning(GO:0046958) phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.1 | GO:0003341 | cilium movement(GO:0003341) axoneme assembly(GO:0035082) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.1 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.2 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 1.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.1 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.1 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.7 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 6.2 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 0.1 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.6 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
0.1 | 0.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.5 | GO:0048925 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:0071674 | mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.1 | 0.2 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 1.1 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0014896 | muscle hypertrophy(GO:0014896) |
0.0 | 0.4 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.7 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.0 | 0.6 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 1.5 | GO:0019395 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.0 | 0.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.8 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.3 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.0 | 0.1 | GO:1901987 | regulation of cell cycle phase transition(GO:1901987) |
0.0 | 0.4 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 1.5 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.5 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 1.2 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 2.4 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0006312 | mitotic recombination(GO:0006312) |
0.0 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.4 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.3 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.2 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.7 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.0 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.0 | 0.7 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.2 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 0.0 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.0 | GO:0098543 | detection of other organism(GO:0098543) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.0 | 0.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.0 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.3 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 3.7 | GO:0006955 | immune response(GO:0006955) |
0.0 | 0.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.0 | 0.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.0 | 0.1 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.0 | 0.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.0 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 0.0 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.4 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.0 | 0.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.0 | 3.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 2.6 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 2.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.8 | 3.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 2.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 4.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.6 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 2.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.6 | 1.7 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.6 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.6 | 2.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.6 | 2.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 1.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.5 | 2.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 5.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.5 | 8.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.5 | 3.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 5.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 9.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 0.5 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.4 | 1.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 3.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 3.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 1.3 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.4 | 2.1 | GO:0070695 | FHF complex(GO:0070695) |
0.4 | 5.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.4 | 3.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.4 | 1.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.4 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 3.6 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 8.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 5.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.1 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 4.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 3.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 3.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 2.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 1.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 2.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 3.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 1.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 0.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 11.9 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.3 | 2.6 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.6 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 2.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 1.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.9 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.3 | 1.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.3 | 3.1 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.3 | 2.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 0.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 2.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 1.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 2.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 2.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 4.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 2.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
0.3 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 0.3 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.3 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 2.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.3 | 0.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.3 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 8.0 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 2.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 4.6 | GO:0005844 | polysome(GO:0005844) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 2.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 3.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 13.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.3 | 1.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 2.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 3.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 26.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.2 | 0.7 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 0.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 1.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 4.2 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 3.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 1.8 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.9 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 0.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 2.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.7 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 5.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 11.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.3 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 17.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.2 | 2.9 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 5.3 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.4 | GO:0038201 | TOR complex(GO:0038201) |
0.2 | 1.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.4 | GO:0030120 | vesicle coat(GO:0030120) clathrin vesicle coat(GO:0030125) |
0.2 | 19.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 1.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 1.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 1.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.2 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 0.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 23.7 | GO:0005769 | early endosome(GO:0005769) |
0.2 | 0.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 2.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 8.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 2.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.2 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.9 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 1.4 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 3.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 3.7 | GO:0015030 | Cajal body(GO:0015030) |
0.2 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 21.4 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 5.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.2 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 2.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 0.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 2.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.0 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 1.0 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 7.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 7.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.5 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 2.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 1.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 0.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.2 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 4.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.6 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 2.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 8.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 3.3 | GO:0009295 | nucleoid(GO:0009295) |
0.1 | 1.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 5.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 11.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 1.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 6.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 4.0 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 3.0 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 4.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 3.7 | GO:0030496 | midbody(GO:0030496) |
0.1 | 54.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 1.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:1990316 | pre-autophagosomal structure(GO:0000407) ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 9.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.6 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.1 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 15.0 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 11.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 5.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 4.0 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:0032059 | bleb(GO:0032059) |
0.1 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 2.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 1.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.6 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 4.6 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 7.7 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 52.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.5 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.1 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 51.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 83.7 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 4.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 2.6 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.1 | 158.6 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 18.4 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.0 | GO:0036379 | striated muscle myosin thick filament(GO:0005863) myofilament(GO:0036379) |
0.0 | 0.5 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.0 | GO:0099738 | cell cortex region(GO:0099738) |
0.0 | 0.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 3.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.9 | 2.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.9 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.8 | 4.2 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 2.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.8 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 4.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.8 | 3.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 0.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.7 | 2.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.7 | 2.0 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 2.7 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.7 | 2.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 3.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.6 | 2.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.6 | 3.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 1.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.6 | 9.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 1.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.5 | 3.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.5 | 1.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 1.6 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 3.1 | GO:0070513 | death domain binding(GO:0070513) |
0.5 | 3.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.5 | 3.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.5 | 1.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.5 | 1.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.5 | 2.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 3.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.5 | 4.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 2.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 2.4 | GO:0009374 | biotin binding(GO:0009374) |
0.5 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 1.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 1.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.4 | 4.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 0.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 5.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.4 | 1.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 3.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 3.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.4 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.4 | 5.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.4 | 2.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.4 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 1.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.4 | 1.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 2.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.4 | 1.2 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.4 | 1.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 1.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 1.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.4 | 1.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 2.3 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.4 | 2.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 1.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 3.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 0.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.4 | 7.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 1.5 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.5 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.4 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.4 | 1.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.4 | 2.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.4 | 1.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.4 | 1.1 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.4 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 5.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.3 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.3 | 3.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 1.0 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 2.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 2.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 5.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 12.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 2.3 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.3 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 9.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.3 | 2.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.3 | 0.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 2.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 1.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 0.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 0.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 1.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 2.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.3 | 0.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 1.8 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.3 | 2.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.3 | 0.9 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.3 | 2.1 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 2.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 5.4 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 2.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 0.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 3.0 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.3 | 0.9 | GO:0004803 | transposase activity(GO:0004803) |
0.3 | 0.6 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 9.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 3.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 2.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 9.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 2.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 3.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.4 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.3 | 1.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.8 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.3 | 1.1 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 2.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.3 | 3.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 0.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.3 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 0.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.3 | 0.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 1.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 1.1 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 0.3 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.3 | 6.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.3 | 1.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 2.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 0.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.3 | 3.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 5.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.3 | 1.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 1.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 2.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 1.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.0 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.5 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 1.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 1.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 2.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 2.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.2 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 11.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 2.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.2 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.6 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 1.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 1.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 7.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 1.7 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.2 | 0.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.2 | 0.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.7 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 15.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 1.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 7.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 0.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 12.6 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.2 | 0.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 7.9 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 3.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 5.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 3.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 2.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 4.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 4.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 2.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 2.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.4 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.2 | 0.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.2 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.2 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 0.7 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 14.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 0.5 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.2 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 1.6 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.2 | 0.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.2 | 2.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.2 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 0.5 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 0.2 | GO:0051287 | NAD binding(GO:0051287) |
0.2 | 1.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 1.4 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.2 | 0.9 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 3.9 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.2 | 4.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.2 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 1.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.5 | GO:0019239 | deaminase activity(GO:0019239) |
0.2 | 0.8 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 0.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 1.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.0 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.2 | 4.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 1.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 9.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 0.6 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 2.0 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.5 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.2 | 2.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 1.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.2 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 1.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 0.5 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.2 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 1.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.2 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 2.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.2 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.5 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 2.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.0 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.9 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.7 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 2.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.6 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 2.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 13.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 2.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 3.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 1.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 11.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.3 | GO:0046970 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) histone deacetylase activity (H4-K16 specific)(GO:0034739) NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.1 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.1 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 5.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.0 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 15.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 17.4 | GO:0016874 | ligase activity(GO:0016874) |
0.1 | 1.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.0 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 4.0 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 1.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 1.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.6 | GO:0032451 | demethylase activity(GO:0032451) |
0.1 | 0.9 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.1 | 3.8 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.5 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 5.9 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.9 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.2 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 4.9 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.1 | 0.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.6 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.1 | 0.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.1 | 1.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 15.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 1.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 0.1 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.1 | 38.5 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0030976 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 15.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.4 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.1 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 1.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.6 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.1 | 0.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 8.5 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 7.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 3.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.8 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 1.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.5 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 1.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.6 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 4.3 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 5.2 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 2.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 1.3 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 90.6 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 12.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 13.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.6 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.4 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 8.2 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 1.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.5 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.1 | 0.2 | GO:0016624 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 2.7 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 5.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 1.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.4 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.0 | 0.7 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.9 | GO:0016829 | lyase activity(GO:0016829) |
0.0 | 0.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.5 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.9 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.4 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 1.0 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.3 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.0 | 0.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.3 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0050661 | NADP binding(GO:0050661) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0004946 | bombesin receptor activity(GO:0004946) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 21.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.7 | 39.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 6.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 8.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.6 | 8.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 3.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 1.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.5 | 6.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 12.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 18.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 3.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 1.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 14.6 | PID FOXO PATHWAY | FoxO family signaling |
0.4 | 9.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 9.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 7.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 5.9 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 2.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 1.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.4 | 1.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 10.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 1.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 2.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 6.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 3.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 3.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 4.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 6.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 0.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 6.2 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 2.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 9.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 1.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 0.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 3.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 3.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 2.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 1.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 3.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 1.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 11.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 7.1 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 6.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 5.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 8.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 7.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 2.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 1.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 1.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 2.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 5.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 4.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 2.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 1.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 5.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 5.7 | PID P73PATHWAY | p73 transcription factor network |
0.2 | 0.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 6.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 4.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 0.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 2.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID AURORA B PATHWAY | Aurora B signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.9 | 0.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.8 | 0.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.8 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.7 | 2.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 10.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 6.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 7.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 7.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 6.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 13.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 6.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.5 | 7.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 1.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.5 | 1.4 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 6.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 0.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.4 | 9.5 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.4 | 18.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 5.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.4 | 2.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 3.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 6.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 4.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 4.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 3.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 7.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.4 | 3.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 3.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 4.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 1.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.3 | 2.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 5.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 6.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 6.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.3 | 11.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 3.9 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 10.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 8.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 2.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 6.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 3.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 0.6 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 4.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 4.5 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.3 | 3.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 5.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 3.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 3.0 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 4.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 4.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 7.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 6.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.2 | 5.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 4.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 2.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 5.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 3.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 15.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 3.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 10.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 4.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 2.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 4.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 7.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 2.5 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.5 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.2 | 2.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 0.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 0.4 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.2 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 0.2 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.2 | 2.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 1.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 3.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.9 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.2 | 0.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 2.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 0.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.8 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 22.8 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.2 | 4.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 3.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 11.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 0.9 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.4 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 10.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 2.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 5.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 7.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 2.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 3.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 2.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.6 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.1 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 3.2 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 6.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 3.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 16.9 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 3.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 2.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 5.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 3.2 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 2.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 6.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 4.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.1 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 3.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.3 | REACTOME CELL CYCLE | Genes involved in Cell Cycle |
0.1 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 3.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.2 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.4 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 3.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 9.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 1.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.7 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |